WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1993019770) COMPOSITIONS FOR THE TREATMENT OF ACUTE OR CHRONIC INFLAMMATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1993/019770    International Application No.:    PCT/GB1993/000719
Publication Date: 14.10.1993 International Filing Date: 06.04.1993
Chapter 2 Demand Filed:    05.11.1993    
IPC:
A61K 35/14 (2006.01), A61K 38/20 (2006.01)
Applicants: ISIS INNOVATION LIMITED [GB/GB]; 2 South Parks Road, Oxford 0X1 3UB (GB) (For All Designated States Except US).
GORDON, Siamon [ZA/GB]; (GB) (For US Only).
STEIN, Michael [ZA/GB]; (GB) (For US Only)
Inventors: GORDON, Siamon; (GB).
STEIN, Michael; (GB)
Agent: PENNANT, Pyers; Stevens, Hewlett & Perkins, 1 Serjeants' Inn, Fleet Street, London EC4Y 1LL (GB)
Priority Data:
9207732.0 06.04.1992 GB
Title (EN) COMPOSITIONS FOR THE TREATMENT OF ACUTE OR CHRONIC INFLAMMATION
(FR) COMPOSITIONS PERMETTANT LE TRAITEMENT D'INFLAMMATIONS AIGUES OU CHRONIQUES
Abstract: front page image
(EN)A composition for the treatment of acute or chronic inflammation, comprising IL-4 and IL-10, or Th-2 cell supernatant, or supernatant of macrophages with a healing phenotype, and a corresponding method of treatment. Macrophages with a healing phenotype are a newly defined group of macrophages, derived from elicited macrophages stimulated with IL-4 and IL-10, or Th-2 cell supernatant, and having a clearly distinguishable phenotype.
(FR)On décrit une composition qui permet le traitement d'inflammations aiguës ou chroniques et comprend IL-4 et IL-10, ou un surnageant de cellules Th-2, ou un surnageant de macrophages dotés d'un phénotype favorisant la guérison. On décrit en outre un traitement correspondant. Les macrophages dotés d'un phénotype favorisant la guérison constituent un groupe de macrophages récemment définis et dérivés de macrophages produits stimulés par IL-4 et IL-10 ou par un surnageant de cellules Th-2, et ils présentent un phénotype nettement différencié.
Designated States: AT, AU, BB, BG, BR, CA, CH, CZ, DE, DK, ES, FI, GB, HU, JP, KP, KR, LK, LU, MG, MN, MW, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SK, UA, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)